Next Article in Journal
Significance of Specific Oxidoreductases in the Design of Hypoxia-Activated Prodrugs and Fluorescent Turn off–on Probes for Hypoxia Imaging
Next Article in Special Issue
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Previous Article in Journal
Pancreatic Cancer and Microenvironments: Implications of Anesthesia
Previous Article in Special Issue
Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor
 
 
Article

Article Versions Notes

Cancers 2022, 14(11), 2685; https://doi.org/10.3390/cancers14112685
Action Date Notes Link
article xml file uploaded 29 May 2022 07:52 CEST Original file -
article xml uploaded. 29 May 2022 07:52 CEST Update -
article pdf uploaded. 29 May 2022 07:52 CEST Version of Record https://www.mdpi.com/2072-6694/14/11/2685/pdf-vor
article html file updated 29 May 2022 07:54 CEST Original file -
article xml file uploaded 2 June 2022 09:57 CEST Update -
article xml uploaded. 2 June 2022 09:57 CEST Update https://www.mdpi.com/2072-6694/14/11/2685/xml
article pdf uploaded. 2 June 2022 09:57 CEST Updated version of record https://www.mdpi.com/2072-6694/14/11/2685/pdf
article html file updated 2 June 2022 10:26 CEST Update -
article html file updated 3 August 2022 02:27 CEST Update https://www.mdpi.com/2072-6694/14/11/2685/html
Back to TopTop